DexCom (DXCM) Short Interest Ratio & Short Volume → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free DXCM Stock Alerts $137.87 +3.87 (+2.89%) (As of 04/24/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability DexCom Short Interest DataCurrent Short Volume14,570,000 sharesPrevious Short Volume15,870,000 sharesChange Vs. Previous Month-8.19%Dollar Volume Sold Short$2.02 billionShort Interest Ratio / Days to Cover4.7Last Record DateMarch 31, 2024Outstanding Shares396,030,000 sharesPercentage of Shares Shorted3.68%Today's Trading Volume3,236,645 sharesAverage Trading Volume2,264,724 sharesToday's Volume Vs. Average143% Short Selling DexCom ? Sign up to receive the latest short interest report for DexCom and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatDXCM Short Interest Over TimeDXCM Days to Cover Over TimeDXCM Percentage of Float Shorted Over Time Ad WealthPress$25,000 into $109,616 in two months? Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. DexCom Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/202414,570,000 shares $2.02 billion -8.2%N/A4.7 $138.70 3/15/202415,870,000 shares $2.07 billion -4.7%N/A5.3 $130.46 2/29/202416,650,000 shares $1.92 billion -2.5%N/A5.4 $115.07 2/15/202417,070,000 shares $2.01 billion -8.0%N/A5.7 $117.69 1/31/202418,560,000 shares $2.25 billion +1.8%N/A5.9 $121.35 1/15/202418,240,000 shares $2.28 billion -0.9%N/A5 $125.00 Get the Latest News and Ratings for DXCM and Related StocksEnter your email address below to receive the latest news and analysts' ratings for DexCom and its competitors with MarketBeat's FREE daily newsletter. 12/31/202318,410,000 shares $2.28 billion -2.9%N/A4.4 $124.09 12/15/202318,960,000 shares $2.32 billion -0.8%N/A4.1 $122.59 11/30/202319,120,000 shares $2.21 billion +7.7%N/A3.9 $115.52 11/15/202317,750,000 shares $1.81 billion -15.7%N/A3.4 $102.11 10/31/202321,060,000 shares $1.87 billion +30.7%N/A4.2 $88.83 10/15/202316,110,000 shares $1.23 billion +2.0%N/A3.5 $76.19 9/30/202315,800,000 shares $1.47 billion -1.4%N/A3.8 $93.30 9/15/202316,030,000 shares $1.54 billion -5.3%N/A4.4 $96.35 8/31/202316,920,000 shares $1.71 billion +0.8%N/A5 $100.98 8/15/202316,780,000 shares $1.92 billion +11.9%N/A5.4 $114.51 7/31/202315,000,000 shares $1.87 billion +21.2%N/A5.3 $124.56 7/15/202312,380,000 shares $1.70 billion -0.2%N/A4.7 $137.32 6/30/202312,410,000 shares $1.59 billion -2.4%N/A5 $128.51 6/15/202312,710,000 shares $1.66 billion -10.9%N/A5.3 $130.98 5/31/202314,260,000 shares $1.67 billion -1.4%N/A6.3 $117.26 5/15/202314,460,000 shares $1.73 billion +13.6%N/A6.5 $119.61 4/30/202312,730,000 shares $1.54 billion +5.4%N/A5.4 $121.34 4/15/202312,080,000 shares $1.40 billion -2.7%N/A5.3 $115.70 3/31/202312,410,000 shares $1.44 billion -1.4%N/A5.1 $116.18 3/15/202312,580,000 shares $1.43 billion -2.7%N/A5.1 $113.72 2/28/202312,930,000 shares $1.44 billion -2.0%N/A4.9 $111.01 2/15/202313,190,000 shares $1.59 billion +18.7%N/A5 $120.17 1/31/202311,110,000 shares $1.19 billion -5.6%N/A4.4 $107.09 1/15/202311,770,000 shares $1.28 billion +1.0%N/A4.3 $108.47 12/30/202211,650,000 shares $1.32 billion -7.0%N/A4.2 $113.24 12/15/202212,530,000 shares $1.46 billion -3.4%N/A4.3 $116.24 11/30/202212,970,000 shares $1.51 billion +3.0%N/A4.6 $116.28 11/15/202212,590,000 shares $1.46 billion +5.8%N/A4.5 $116.31 10/31/202211,900,000 shares $1.44 billion -13.1%N/A4.3 $120.78 10/15/202213,690,000 shares $1.33 billion +4.5%N/A4.8 $97.41 9/30/202213,100,000 shares $1.06 billion -14.1%N/A4.8 $80.54 9/15/202215,250,000 shares $1.39 billion +6.3%N/A5.9 $90.98 8/31/202214,350,000 shares $1.18 billion +7.2%N/A5.2 $82.21 8/15/202213,390,000 shares $1.24 billion +10.2%N/A4 $92.30$25,000 into $109,616 in two months? (Ad)Today I want to show you how our research shows you could’ve grown a $25,000 account into $109,616.12 within the last TWO months. You see, former multi-million dollar hedge fund manager Roger Scott spent the better half of 2023 developing what might be the most advanced trading tool that exists… It’s a revolutionary software system that tracks the moves of institutional investors…. in real time…Go here to watch the most recent trading workshop video at no charge. DXCM Short Interest - Frequently Asked Questions What is DexCom's current short interest? Short interest is the volume of DexCom shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 14,570,000 shares of DXCM short. Learn More on DexCom's current short interest. What is a good short interest ratio for DexCom? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. DXCM shares currently have a short interest ratio of 5.0. Learn More on DexCom's short interest ratio. Which institutional investors are shorting DexCom? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of DexCom: Portman Square Capital LLP, HBK Investments L P, Caas Capital Management LP, Citadel Advisors LLC, Capital Fund Management S.A., PEAK6 Investments LLC, Capstone Investment Advisors LLC, Allianz Asset Management GmbH, Hsbc Holdings PLC, IMC Chicago LLC, UBS Group AG, BNP Paribas Financial Markets, Concourse Financial Group Securities Inc., Genus Capital Management Inc., and Valeo Financial Advisors LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. Is DexCom's short interest increasing or decreasing? DexCom saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 14,570,000 shares, a drop of 8.2% from the previous total of 15,870,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does DexCom's short interest compare to its competitors? Here is how the short interest of companies compare to DexCom: 3M (1.37%), ResMed Inc. (5.36%), Baxter International Inc. (1.50%), Insulet Co. (4.46%), Teleflex Incorporated (1.89%), NovoCure Limited (5.20%), Boston Scientific Co. (0.85%), West Pharmaceutical Services, Inc. (1.55%), Edwards Lifesciences Co. (1.75%), Cencora, Inc. (4.70%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short DexCom stock? Short selling DXCM is an investing strategy that aims to generate trading profit from DexCom as its price is falling. DXCM shares are trading up $3.87 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against DexCom? A short squeeze for DexCom occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DXCM, which in turn drives the price of the stock up even further. How often is DexCom's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DXCM, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: 3M Short Squeeze ResMed Short Squeeze Baxter International Short Squeeze Insulet Short Squeeze Teleflex Short Squeeze NovoCure Short Squeeze Boston Scientific Short Squeeze West Pharmaceutical Services Short Squeeze Edwards Lifesciences Short Squeeze Cencora Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:DXCM) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersHe Is Giving Away BitcoinCrypto Swap ProfitsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Presstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe #1 Crypto for 2024InvestorPlaceEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsFed launches fourth dollar overhaulStansberry ResearchUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American Alternative1970’s computer coder issues shocking A.I. warningTradeSmith